QQ客服 官方微博 反馈留言

	Chidamide in relapsed or refractory peripheral T cell lymphoma: A multicenter real-world study in China
	Shi, Y.; Jia, B.; Xu, W.; Li, W.; Liu, T.; Liu, P.; Zhao, W.; Zhang, H.; Sun, X.; Yang, H.
刊名	Journal of Hematology and Oncology
	2017
卷号	Vol.10 No.1
关键词	Chemotherapy Chidamide Peripheral T cell lymphoma Treatment
ISSN号	1756-8722
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/1821168
专题	四川大学
作者单位	1.aj Second Hospital of Hebei Medical University, Shijiazhuang, China 2.t Nanjing Drum Tower Hospital, Nanjing, China 3.aq Second Affiliated Hospital Zhejiang University, School of Medicine, Hangzhou, China 4.Peking University Cancer Hospital and Institute, Beijing, China 5.m First Affiliated Hospital of Soochow University, Suzhou, China 6.y General Hospital of Nanjing Military Region, Nanjing, China 7.g Shanghai Ruijin Hospital, Shanghai, China 8.ad Anhui Provincial Hospital, Hefei, China 9.z Changhai Hospital, Shanghai, China 10.at Wuhan Union Hospital of China, Wuhan, China
推荐引用方式 GB/T 7714	Shi, Y.,Jia, B.,Xu, W.,et al. Chidamide in relapsed or refractory peripheral T cell lymphoma: A multicenter real-world study in China[J]. Journal of Hematology and Oncology,2017,Vol.10 No.1.
APA	Shi, Y..,Jia, B..,Xu, W..,Li, W..,Liu, T..,...&Zhang, Y..(2017).Chidamide in relapsed or refractory peripheral T cell lymphoma: A multicenter real-world study in China.Journal of Hematology and Oncology,Vol.10 No.1.
MLA	Shi, Y.,et al."Chidamide in relapsed or refractory peripheral T cell lymphoma: A multicenter real-world study in China".Journal of Hematology and Oncology Vol.10 No.1(2017).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。